Deborah DiSanzo Eldracher - 17 Oct 2022 Form 4 Insider Report for BEST BUY CO INC (BBY)

Reporting relationship: President, Best Buy Health
Issuer ticker: BBY
Reported as of: 17 Oct 2022
Net transaction value: -$1,808
SEC form: 4
Accepted by SEC: 18 Oct 2022, 16:28:36 UTC
Prior SEC filing: 23 Sep 2022
Source filing: View source filing
Reporting owner signature: /s/ Hannah G. Olson, Attorney-in-fact

Key filing fact

Deborah DiSanzo Eldracher filed Form 4 for BEST BUY CO INC (BBY) on 18 Oct 2022.

Key facts

This page summarizes Deborah DiSanzo Eldracher's Form 4 filing for BEST BUY CO INC (BBY).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 18 Oct 2022, 16:28.

Change

Previous filing in this sequence was filed on 23 Sep 2022.
Current net transaction value: -$1,808.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BBY transaction

Common Stock

Sale

Transaction value: $1,808
Shares: -28
Change %: -0.13%
Price: $64.58
Shares after: 21,412
Date: 17 Oct 2022
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents the number of shares sold by the reporting person to cover tax withholding obligations upon the vesting of restricted shares and does not represent a discretionary transaction by the reporting person.

Footnote F2

This number reflects a periodic acquisition of shares under a dividend reinvestment plan exempt from reporting under Section 16b-3(c).